• AMAG Pharma Sells Off Women's Health Product in Planned Divestment

    4 days ago - By Xconomy

    AMAG Pharmaceuticals wants out of the women's health business-and now it's halfway there. On Thursday the Waltham, MA-based biotech said it had found a buyer for prasterone , a steroid designed to treat pain during intercourse associated with menopause, one of two commercialized drugs it has been shopping around. The buyer of the AMAG Pharma product is Ireland-based Millicent Pharma, a company formed in 2018 by a group of industry veterans and New York private equity firm The Carlyle Group. Millicent specializes in women's health and menopause-related conditions; it launched with a vaginal...
    Read more ...